Skip to main content
SpringerLink
Log in

Carcinoma del cavo orale

  • Chapter
Book cover Tumori della testa e del collo

  • 882 Accesses

Riassunto

L’incidenza annual e dei carcinomi squamosi del cavo orale è pari a circa 300.000 nuovi casi l’anno con i maggiori picchi nei paesi poco industrializzati, in relazione a particolari abitudini di vita; il paese più colpito in assoluto è l’India, dove le neoplasie orali costituiscono circa il 40% di tutti i tumori maligni. In Italia l’incidenza è pari a 0,4 casi per 100.000 abitanti. Il rapporto tra maschi e femmine, in passato pari a 8–10:1, è attualmente pari a 2–3:1 in seguito alla maggiore abitudine al tabagismo e al consumo di alcol nelle donne, ma anche alla sempre più frequente comparsa di queste neoplasie in giovani donne anche in assenza dei più comuni fattori di rischio [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliografia

  1. Bailey BJ, Johnson JT, Newlands SD (2006) Head and neck Surgery — Otolaryngology, 4 edn. Lippincott Williams 6 Wilkins, Philadelphia

    Google Scholar 

  2. Angiero F, Gatta LB, Seramondi R et al (2010) Frequency and role of HPV in the progression of epithelial dysplasia to oral cancer. Anticancer Res 30:3435–3440

    PubMed  CAS  Google Scholar 

  3. Syrijanen S (2010) The Role of Human papillomavirus infection in Head and Neck Cancers. Ann Oncol; 21suppl 7:vii243–245

    Article  Google Scholar 

  4. Bachar G, Hod R, Goldstein DP et al (2011) Outcome of oral tongue squamous celle carcinoma in patients with or without known risk factors. Oral Oncol 47:45–50

    Article  PubMed  CAS  Google Scholar 

  5. Princi ME, Sivanandan R, Kaczorowski A et al (2007) Identification of a subpopulation of cells with cancer step cells properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 104:973–978

    Article  Google Scholar 

  6. 6. AJCC (2010) TNM Classification of Malignant Tumours. 7 edn Springer, New York

    Google Scholar 

  7. Patel SG, Shah J (2005) TNM Staging of cancers of the head and neck: striving for uniformity among diversity. CA Cancer J Clin 55:242–258

    Article  PubMed  Google Scholar 

  8. De Vita VT Jr, Lawrence TS, Rosenberg SA (2008) Cancer. Principles & practice of Oncology. 8 edn. Lippincott Williams & Wilkins, Philadelphia

    Google Scholar 

  9. 10. SIO (2007) Linee guida diagnostiche e terapentiche delle neoplasie del cavo orale. Argomenti di Acta Otorinolaryngologica Italica 1:56–71

    Google Scholar 

  10. Myers JN, Greenberg JS, Mo V, Roberts D (2001) Extracapsular spread. A significant predictor of treatment failure in patients with squamous cell carcinoma of the tongue. Cancer 92:3030–3036

    CAS  Google Scholar 

  11. Huang SH, Hwang D, Lockwood G et al (2009) Predictive value of tumor thickness for cervical lymph-node involvement in squamous cell carcinoma of the oral cavity: a metaanalysis of reported studies. Cancer 115:1489–1497

    Article  PubMed  CAS  Google Scholar 

  12. Chakrabarti B, Ghorai S, Basu B et al (2010) Late nodal metastasis in early-stage node-negative oral cavity cancers after successful sole interstitial brachytherapy: an institutional experience of 42 cases in India. Brachytherapy 9:254–259

    Article  PubMed  Google Scholar 

  13. Yamazaki H, Inoue T, Yoshida K et al (2009) Lymph node metastasis of early oral tongue cancer after interstitial radiotherapy. Int J Radiat Oncol Biol Phys 58:139–146

    Article  Google Scholar 

  14. Mazeron JJ, Ardiet JM, Haie Méder C et al (2009) GEC-ESTRO recommendation for brachytherapy for head and neck squamous cell carcinoma. Radiother Oncol 91:150–156

    Article  PubMed  Google Scholar 

  15. Shibuya H (2009) Current status and perspective of brachytherapy for head and neck cancer. Int J Clin Oncol 14:2–6

    Article  PubMed  Google Scholar 

  16. Dearnaley DP, Dardoufas C, A’Hearn RP, Henk JM (1991) Interstitial irradiation for carcinoma of the tongue and floor of mouth: Royal Marsden Hospital Experience 1970-1986. Radiother Oncol 21:183–192

    Article  PubMed  CAS  Google Scholar 

  17. Do L, PuthawalaA, Syed N (2009) Interstitial brachytherapy as boost for locally advanced T4 head and neck cancer. Brachytherapy 8:385–391

    Article  PubMed  Google Scholar 

  18. Marcus RB Jr, Million RR, Cassissi NJ (1979) Postoperative irradiation for squamous cell carcinomas of the head and neck; analysis of tune-dose factors related to control above the clavicles. Int J Radiat Oncol Biol Phys 5:1943–1949

    Article  PubMed  Google Scholar 

  19. Barkley HT Jr, Fletcher GH, Jesse RH, Lindberg RD (1972) Management of cervical lymph node metastases in squamous cell carcinoma of the tonsillar fossa, base of tongue, supraglottic larynx and hypopharynx. Am J Surg 124:462–467

    Article  PubMed  Google Scholar 

  20. Kao J, Lavf A, Teng MS et al (2008) Adjuvant radiotherapy and survival for patients with node-positive head and neck cancer: an analysis by primary site and nodal stage. Int J Radiat Oncol Biol Phys 71:362–370

    Article  PubMed  Google Scholar 

  21. Lavaf A, Genden EM, Cesaretti JA et al (2008) Adiuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma. Cancer 112:535–543

    Article  PubMed  Google Scholar 

  22. Robertson AG, Soutar DS, Paul J et al (1998) Early closure of a randomized trial: surgery and postoperative radiotherapy versus radiotherapy in the management of intra-oral tumor. Clin Oncol 10:155–160

    Article  CAS  Google Scholar 

  23. Bernier J, Domenge C, Ozsahin M et al (200i) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350:1945–1952

    Google Scholar 

  24. Cooper JS, Pajak TF, Forastiere AA et al (2004) Postoperative concurrent radiotherapy and chemotherapy for highrisk squamous-cell carcinoma of the head and neck. N Engl J Med 350:1937–1944

    Article  PubMed  Google Scholar 

  25. Shrime MG, Gullane PJ, Dawson L et al (2010) The impact of adjuvant radiotherapy on survival in T1-T2N1 squamous cell carcinoma of the oral cavity. Arch Otolaryngol Head and Neck Surg 136:225–229

    Article  Google Scholar 

  26. Licitra L, Grandi C, Guzzo Met al (2003) Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial. J Clin Oncol 21:327–333

    Article  PubMed  CAS  Google Scholar 

  27. Driemel O, Ettl T, Kolbl O et al (2009) Outcome and histopathologic regression in oral squamous cell carcinoma after preoperative radiochemotherapy. Strahlenther, Onkol 185:296–302

    Article  Google Scholar 

  28. Eich HT, Loschcke M, Scheer M et al (2008) Neoadjuvant radiochemotherapy and radical resection for advanced squamous cell carcinoma of the oral cavity. Outcome of 134 patients. Strahlenther Onkol 184:23–29

    Article  Google Scholar 

  29. Mohr C, Bohndorf W, Carstens J et al (1994) Preoperative radiochemotherapy and radical surgery in comparison with radical surgery alone. A prospective, multicentric, randomized DOSAK study of advanced squamous cell carcinoma of the oral cavity and oropharynx (a 3 years follow-up). Int J Oral Maxillofac Surg 23:140–148

    Article  PubMed  CAS  Google Scholar 

  30. Volling P, Schroder M, Eckel H et al (1999) Results of a prospective randomized trial with induction chemotherapy for cancer of oral cavity and tonsils. HNO 47:899–906

    Article  PubMed  CAS  Google Scholar 

  31. Nag S, Schuller DE, Martinez-Monge R et al (1998) Intraoperative electron beam radiotherapy for previously irradiated advanced head and neck malignancies. Int J Radiat Oncol Biol Phys 42:1085–1089

    Article  PubMed  CAS  Google Scholar 

  32. Ling SM, Roach M 3rd, Fu KK et al (1996) Local control after the use of adjuvant electron beam intraoperative radiotherapy in patients with high-risk head and neck cancer: the UCSF experience. Cancer J Sci Am 2:321–329

    PubMed  CAS  Google Scholar 

  33. Chen AM, Bucci MK, Singer MI et al (2007) Intraoperative radiotherapy for recurrent head-and-neck cancer: the UCSF experience. Int J Radiat Oncol Biol Phys 67:122–129

    Article  PubMed  Google Scholar 

  34. Calvo FA, Meirino RM, Orecchia R (2006) Intraoperative radiation therapy part 2. Clinical results. Crit Rev Oncol Hematol 59:116–127

    Article  Google Scholar 

  35. Pignon JP, le Maítre A, Maillard E, Bourhis J (2009) Metaanalysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomized trials and 17,346 patients. Radiother Oncol 92:4–14

    Article  PubMed  Google Scholar 

  36. Bonner JA, Harari PM, Giralt J et al (2010) Radiotherapy plus cetuximab for locally advanced head and neck cancer: 5-years survival data from a phase 3 randomized trial, and relation between cetuximab-induced rash and survival. Lancet Oncol 11:21–28

    Article  PubMed  CAS  Google Scholar 

  37. Schiefke F, Hildebrandt G, Pohlmann S et al (2008) Combination of surgical resection and HDR-brachytherapy in patients with recurrent or advanced head and neck carcinomas. J Craniomaxillofac Surg 36:285–292

    Article  PubMed  Google Scholar 

  38. Hepel T, Syed AM, PuthawalaA (2005) Salvage high-doserate (HDR) brachytherapy for recurrent head-and-neck cancer. Int J Radiat Oncol Biol Phys 62:1444–1450

    Article  PubMed  Google Scholar 

  39. Puthawala A, Nisar Syed AM, Garnie S et al (2001) Interstitial low-dose-rate brachyterapy as a salvage treatment for recurrent head-and-neck cancer: long-term results. Int J Radiat Oncol Biol Phys 51:354–362

    PubMed  CAS  Google Scholar 

  40. Daly ME, Lieskovsky Y, Pawlicki T et al (2007) Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma. Head ieck 29:211–220

    Article  Google Scholar 

  41. Studer G, Studer SP, Zwahlen RA et al (2006) Osteoradionecrosis of the mandible: minimized risk profile following In tensity-Modulated Radiation Therapy (IMRT). Strahlenther Oncol 182:283–288

    Article  Google Scholar 

  42. Sheng K, Molloy JA, Read PW (2006) Intensity-modulated radiation therapy (IMRT) dosimetry of the head and neck: a comparison of treatment plans using linear accelerator-based IMRT and helical tomotherapy. Int J Radiat Oncol Biol Phys 65:917–923

    Article  PubMed  Google Scholar 

  43. Peters Li, Ang KK, Thames HD Jr (1988) Accelerated fractionation in the radiation treatment of head and neck cancer. A critical comparison of different strategies. Acta Oncol 27:185–194

    CAS  Google Scholar 

  44. Fu KK, Pajak TF, Trotti A et al (2000) Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinoma: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48:7–16

    Article  PubMed  CAS  Google Scholar 

  45. Lefebvre JL, Coche-Dequeant B, Buisset E (1994) Management of early stage oral cavity cancer. Experience of Centre Oscar Lambret. Eur J Cancer B Oral Oncol 30B:216–220

    Article  PubMed  CAS  Google Scholar 

  46. Rudoltz MS, Perkins RS, Luthman RW (1999) High-doserate brachytherapy for primary carcinoma of the oral cavity and oropharynx. Laryngoscope 109:1967–1973

    Article  PubMed  CAS  Google Scholar 

  47. Nag S, Koc M, Schuller DE et al (2005) Intraoperative single fraction high-dose-rate brachyterapy for head and neck cancer. Brachytherapy 4:217–223

    Article  PubMed  Google Scholar 

  48. Strnad V, Geiger M, Lotter M, Sauer R (2003) The role of pulsed-dose-rate brachyterapy in previously irradiated headand-neck cancer. Brachytherapy 2:158–163

    Article  PubMed  Google Scholar 

  49. Jereczek-Fossa BA, Krengli M, Orecchia R (2006) Particle beam radiotherapy for head and neck tumors: radiobiological basis and clinical experience. Head Neck 28:750–760

    Article  PubMed  Google Scholar 

  50. Bernier J, Cooper JS, Pajak TF et al (2005) Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931 ) and RTOG (# 9501). Head Neck 27:843–850

    Article  PubMed  Google Scholar 

  51. Fietkau R, Lautensehlager C, Sauer R (2006) Postoperative concurrent radiochemotherapy versus radiotherapy in high risk SCCA of the head and neck. Proc Am Soc Clin Oncol, abst 5507

    Google Scholar 

  52. Pignon J-P, Bourhis J, Domenge C, Designé L (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet 255:949–955

    Google Scholar 

  53. Posner MR, Hershock DM, Blajamn CR et al (2007) Cisplatin andfluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357:1705–1715

    Article  PubMed  CAS  Google Scholar 

  54. Vermorken JB, Remenar E, van Herpen C et al (2007) Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357:1695–1704

    Article  PubMed  CAS  Google Scholar 

  55. Hitt R, López-Pousa A, Martíunez-Trufero J et al (2006) Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol 23:8636–8645

    Article  Google Scholar 

  56. Vermorken JB, Mesia R, Rivera F et al (2008) Platinum based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 359:1116–1127

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dipartmento di Chirurgia Cervico-Facciale, IEO - Istituto Europeo di Oncologia, Milano, Italia

    Fausto Chiesa

Authors
  1. Fausto Chiesa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniela Alterio
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maria Grazia Ghi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Adriano Paccagnella
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Italia

About this chapter

Cite this chapter

Chiesa, F., Alterio, D., Ghi, M.G., Paccagnella, A. (2011). Carcinoma del cavo orale. In: Tumori della testa e del collo. Springer, Milano. https://doi.org/10.1007/978-88-470-1806-8_26

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-1806-8_26

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-1805-1

  • Online ISBN: 978-88-470-1806-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation